Mon. 11 Mar 2024, 6:42am ET
Benzinga
Earnings, News
KalVista Pharma (NASDAQ:KALV) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.77) by 9.09 percent. This is a 12 percent decrease over losses of $(0.75) per share from the same period last year.